Full Conference Agenda

Home / Schedule / Full Conference Agenda

Abstract Details

<< Back to Detailed Agenda

9/09/2025  |   12:00 PM - 12:50 PM   |  Memorial Hall

Jamie McNew Memorial Lecture in Congenital CMV Research "The Conquest of Rubella: A Prelude to Vaccination against CMV?"

Presentation

3578581_18538StanleyPlotkin.pdf

Handouts

No handouts have been uploaded.

Presenters


Mark R. Schleiss | Primary Presenter

schleiss@umn.edu ;
Dr. Schleiss is a Professor of Pediatrics and holds the American Legion and Auxiliary Endowed Research Chair at the University of Minnesota Medical School. His laboratory is supported by the NIH. He conducts research in small animal models testing vaccine strategies against congenital CMV infection. His laboratory is also engaged in the study of the epidemiology, pathogenesis and management of congenital and neonatal CMV infections.

ASHA DISCLOSURE

Financial - No relevant financial relationship exists.

Nonfinancial - No relevant nonfinancial relationship exists.

AAA DISCLOSURE

Financial - Receives support from Moderna Vaccines CDC National Institutes of Health (NIH) for Research Support Site PI for Moderna mRNA-1647 Vaccune Study.  


Stanley Plotkin | Primary Presenter

stanley.plotkin@vaxconsult.com;
Dr. Stanley A. Plotkin is Emeritus Professor of the University of Pennsylvania. Until 1991, he was Professor of Pediatrics and Microbiology at the University of Pennsylvania, Professor of Virology at the Wistar Institute and at the same time, Director of Infectious Diseases and Senior Physician at the Children’s Hospital of Philadelphia. He is now consultant to vaccine manufacturers and non-profit research organizations. He is a member of the Institute of Medicine of the National Academy of Sciences and the French Academy of Medicine. His bibliography includes 700 articles and he has edited several books including a textbook on vaccines. He developed the rubella vaccine now in standard use throughout the world, is codeveloper of the newly licensed pentavalent rotavirus vaccine, and has worked extensively on the development and application of other vaccines including anthrax, oral polio, rabies, varicella, and cytomegalovirus.

ASHA DISCLOSURE

Financial -

Nonfinancial -

AAA DISCLOSURE

Financial - No relevant financial relationship exists.